
Duliva 30mg Capsule DR
Marketer
Kuresys Labs
Salt Composition
Duloxetine (30mg)
Overview Duliva 30mg Capsule DR
Duliva 30mg extended-release capsules treat various conditions, including depression, anxiety, diabetic neuropathy, fibromyalgia (characterized by widespread body pain and tenderness), neuropathic pain, and stress incontinence. This medication elevates brain levels of serotonin and noradrenaline, neurotransmitters promoting calmness and nerve relaxation, thereby alleviating symptoms. It can be administered with or without food, ideally at the same time daily for consistent blood levels. Missed doses should be taken promptly upon recall; complete the prescribed course, even with symptom improvement. Abrupt cessation is contraindicated due to potential symptom exacerbation. Common, generally transient side effects may include nausea, headache, reduced libido, vivid dreams, blurred vision, dry mouth, dizziness, and drowsiness. Avoid activities requiring alertness until the medication's effects are known. Persistent or bothersome side effects warrant medical consultation. Prior to commencing treatment, disclose any kidney, heart, liver problems, or history of seizures to your physician. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation immediately.
Uses of Duliva 30mg Capsule DR
Managing diabetic neuropathy | Addressing depressive symptoms | Anxiety disorder management | Neuropathic pain relief | Fibromyalgia symptom control | Stress incontinence treatment
Major Benefits of Duliva 30mg Capsule DR:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the 30mg Duliva DR capsule whole; avoid chewing, crushing, or fracturing. Consumption with or without food is acceptable, though consistent timing is recommended.
Common Side effects of Duliva 30mg Capsule DR:
- Nausea
- Headache
- Dryness in mouth
- Sleepiness
- Dizziness
- Blurred vision
- Decreased libido
- Abnormal dreams
How to use Duliva 30mg Capsule DR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Duliva 30mg Delayed-Release Capsules. Ingest the capsules whole; do not crush, chew, or break them. While Duliva 30mg DR Capsules can be taken with or without food, consistent timing is recommended.
How Duliva 30mg Capsule DR works:
Duliva 30mg delayed-release capsules elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium and the inhibition of pain signals.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Duliva 30mg Capsule DR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Duliva 30mg Delayed-Release Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks before recommending this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Duliva 30mg Delayed-Release Capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Duliva 30mg Delayed-Release Capsule might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Exercise caution when administering Duliva 30mg Delayed-Release Capsules to individuals with advanced renal impairment. Dosage modification of Duliva 30mg Delayed-Release Capsules might be necessary. Physician consultation is advised.
LiverUNSAFE
Patients with liver impairment should not take Duliva 30mg DR capsules; their use is considered unsafe. Medical advice is recommended.
What if you forget to take Duliva 30mg Capsule DR :
Forgetting a Duliva 30mg Capsule DR? Take it immediately if you remember. But, if your next dose is nearly due, omit the missed one and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Duliva 30mg Capsule DR
| Label | Value |
|---|---|
| Chemical Type | Naphthalenic Compound |
| Developing Habits | No. |
| Type of Therapy | Neuroscience (Central Nervous System) |
